{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:48:06Z","timestamp":1741153686180,"version":"3.38.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Circulating cardiac troponin-I (cTnI) plays a crucial role in biomarker staging systems, offering important information for prognostification and risk stratification of patients with AL amyloidosis. High-sensitivity cTnI (HS-cTnI) assays have been introduced in practice; however, the data on the concordance between conventional and HS-cTnI and the utility of HS-cTnI in cardiac biomarker staging are lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Seventy-eight consecutive patients with AL amyloidosis who were prospectively evaluated at the Boston University Amyloidosis Center from October 2022 through March 2023 were included. cTnI was measured using the Abbott Architect cTnI chemiluminescent microparticle immunoassay (CMIA) and HS-cTnI using the Abbott Alinity HS-cTnI CMIA assay. Assay results were compared by Deming regression and Bland\u2013Altman analyses, and cardiac biomarker stages were assigned and compared using both assay results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Median cTnI and HS-cTnI concentrations were 13.0 and 7.0\u2005ng\/L, respectively. Bland\u2013Altman analysis demonstrated a negative bias with HS-cTnI results (mean percent difference between assays: \u221249.8%) and the greatest variance occurring below 50\u2005ng\/L. Deming regression supported this negative discordance (slope, 0.66; intercept, \u22121.9). The use of HS-cTnI assay downgraded cardiac biomarker staging assignments from stage IIIA to stage II (n = 3) and from stage IIIB to stage II (n = 1).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Overall agreement was demonstrated; however, a negative bias for HS-cTnI assay was noted at low concentrations. The application of the conventional cTnI threshold of &amp;gt;100\u2005ng\/L to HS-cTnI-based Boston University cardiac staging showed a trend toward downgraded staging assignments. The prognostic utility of HS-cTnI assay in biomarker staging warrants further investigation in patients with AL amyloidosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jalm\/jfae111","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T14:12:10Z","timestamp":1730729530000},"page":"315-324","source":"Crossref","is-referenced-by-count":0,"title":["High-Sensitivity and Conventional Cardiac Troponin-I Assays in AL Amyloidosis"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2348-9465","authenticated-orcid":false,"given":"Maura C","family":"Dodge","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Boston Medical Center , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Prokaeva","sequence":"additional","affiliation":[{"name":"Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Mendelson","sequence":"additional","affiliation":[{"name":"Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Joshi","sequence":"additional","affiliation":[{"name":"Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[{"name":"Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6249-7134","authenticated-orcid":false,"given":"Yachana","family":"Kataria","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Boston Medical Center , Boston, MA ,","place":["United States"]},{"name":"Department of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"2025030423061636600_jfae111-B1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/jcp.2003.015420","article-title":"Cardiac troponins","volume":"57","author":"Sharma","year":"2004","journal-title":"J Clin Pathol"},{"issue":"Pt 5","key":"2025030423061636600_jfae111-B2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/000456320103800501","article-title":"Measurement of cardiac troponins","volume":"38","author":"Collinson","year":"2001","journal-title":"Ann Clin Biochem"},{"author":"Witteles","key":"2025030423061636600_jfae111-B3"},{"key":"2025030423061636600_jfae111-B4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(03)13396-X","article-title":"Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins","volume":"361","author":"Dispenzieri","year":"2003","journal-title":"Lancet"},{"key":"2025030423061636600_jfae111-B5","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2010-05-286567","article-title":"The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis","volume":"116","author":"Palladini","year":"2010","journal-title":"Blood"},{"key":"2025030423061636600_jfae111-B6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2018-06-858951","article-title":"Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis","volume":"133","author":"Lilleness","year":"2019","journal-title":"Blood"},{"key":"2025030423061636600_jfae111-B7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1373\/clinchem.2016.255109","article-title":"Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care","volume":"63","author":"Apple","year":"2017","journal-title":"Clin Chem"},{"key":"2025030423061636600_jfae111-B8","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1001\/jama.2011.1896","article-title":"Serial changes in highly sensitive Troponin I assay and early diagnosis of myocardial infarction","volume":"306","author":"Keller","year":"2011","journal-title":"JAMA"},{"key":"2025030423061636600_jfae111-B9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41408-022-00732-3","article-title":"Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study","volume":"12","author":"Long","year":"2022","journal-title":"Blood Cancer J"},{"key":"2025030423061636600_jfae111-B10","volume-title":"Contemporary practice in clinical chemistry","author":"Clark","year":"2021","edition":"2nd Ed"},{"key":"2025030423061636600_jfae111-B11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"2025030423061636600_jfae111-B12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"key":"2025030423061636600_jfae111-B13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaccao.2022.08.011","article-title":"Outcomes by cardiac stage in patients with newly diagnosed AL amyloidosis: phase 3 ANDROMEDA trial","volume":"4","author":"Minnema","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2025030423061636600_jfae111-B14","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/eurheartj\/ehs154","article-title":"How to use high-sensitivity cardiac troponins in acute cardiac care","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"2025030423061636600_jfae111-B15","doi-asserted-by":"crossref","first-page":"e000204","DOI":"10.1161\/JAHA.113.000204","article-title":"High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice?","volume":"2","author":"Hammerer-Lercher","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2025030423061636600_jfae111-B16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cca.2010.12.034","article-title":"Multicenter analytical evaluation of a high-sensitivity troponin T assay","volume":"412","author":"Saenger","year":"2011","journal-title":"Clin Chim Acta"},{"key":"2025030423061636600_jfae111-B17","first-page":"100758","article-title":"Comparing conventional and high sensitivity troponin T measurements in identifying adverse cardiac events in patients admitted to an Asian emergency department chest pain observation unit","volume":"34","author":"Lin","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2025030423061636600_jfae111-B18","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood-2010-02-267708","article-title":"Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay","volume":"116","author":"Kristen","year":"2010","journal-title":"Blood"},{"key":"2025030423061636600_jfae111-B19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/heartjnl-2013-304957","article-title":"High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis","volume":"100","author":"Dispenzieri","year":"2014","journal-title":"Heart"},{"key":"2025030423061636600_jfae111-B20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1200\/JCO.18.01398","article-title":"Validation of Mayo Clinic staging system for light chain amyloidosis with high-sensitivity troponin","volume":"37","author":"Kumar","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/10\/2\/315\/60413102\/jfae111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/10\/2\/315\/60413102\/jfae111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T23:06:39Z","timestamp":1741129599000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/10\/2\/315\/7874933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,11,4]]},"published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfae111","relation":{},"ISSN":["2475-7241"],"issn-type":[{"type":"electronic","value":"2475-7241"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,11,4]]}}}